Positions
PhD
Duration: 5 y
Immunotherapy has sparked new hope for oncology in recent years, due to its remarkable ability to induce durable response in patients with metastatic cancer. It is therefore essential to accurately delineate the interactions of cancer cells with the immune system. The project will use multiomic tools including whole exome sequencing , RNAseq, ribosome profiling, proteomic, HLA-peptidomics and systems biology to decipher the genetic, neo-antigenic and immune landscape in melanoma. Followup functional and immunological analysis of relevant genes and neoantigens will be conducted using novel mouse models
Within the past decade, major advances have been made in the treatment of melanoma through the use of targeted therapy and immunotherapy, however responses are not universal and are not always durable. The project aims to further delineate the interactions of melanoma cells with the immune system to better understand molecular and immune mechanisms of therapeutic response and resistance. Our lab combines genomic tools, systems biology tools, advanced somatic cell knockout and knock-in techniques and various comprehensive mouse model approaches to study melanoma immune-genetics. Our studies link basic biology, computational biology and clinical studies. Trainees will learn sophisticated technologies such as whole exome sequencing, Riboseq, HLA-peptidomics, somatic cell knockouts and expression and proteomic analyses. Candidates who wish to join the group may contact me at: Yardena.samuels@weizmann.ac.il
MSc
Duration: 3 y
Immunotherapy has sparked new hope for oncology in recent years, due to its remarkable ability to induce durable response in patients with metastatic cancer. It is therefore essential to accurately delineate the interactions of cancer cells with the immune system. The project will use multiomic tools including whole exome sequencing , RNAseq, ribosome profiling, proteomic, HLA-peptidomics and systems biology to decipher the genetic, neo-antigenic and immune landscape in melanoma. Followup functional and immunological analysis of relevant genes and neoantigens will be conducted using novel mouse models
Within the past decade, major advances have been made in the treatment of melanoma through the use of targeted therapy and immunotherapy, however responses are not universal and are not always durable. The project aims to further delineate the interactions of melanoma cells with the immune system to better understand molecular and immune mechanisms of therapeutic response and resistance. Our lab combines genomic tools, systems biology tools, advanced somatic cell knockout and knock-in techniques and various comprehensive mouse model approaches to study melanoma immune-genetics. Our studies link basic biology, computational biology and clinical studies. Trainees will learn sophisticated technologies such as whole exome sequencing, Riboseq, HLA-peptidomics, somatic cell knockouts and expression and proteomic analyses. Candidates who wish to join the group may contact me at: Yardena.samuels@weizmann.ac.il
Postdoc
Duration: 2 y
Immunotherapy has sparked new hope for oncology in recent years, due to its remarkable ability to induce durable response in patients with metastatic cancer. It is therefore essential to accurately delineate the interactions of cancer cells with the immune system. The project will use multiomic tools including whole exome sequencing , RNAseq, ribosome profiling, proteomic, HLA-peptidomics and systems biology to decipher the genetic, neo-antigenic and immune landscape in melanoma. Followup functional and immunological analysis of relevant genes and neoantigens will be conducted using novel mouse models
Within the past decade, major advances have been made in the treatment of melanoma through the use of targeted therapy and immunotherapy, however responses are not universal and are not always durable. The project aims to further delineate the interactions of melanoma cells with the immune system to better understand molecular and immune mechanisms of therapeutic response and resistance. Our lab combines genomic tools, systems biology tools, advanced somatic cell knockout and knock-in techniques and various comprehensive mouse model approaches to study melanoma immune-genetics. Our studies link basic biology, computational biology and clinical studies. Trainees will learn sophisticated technologies such as whole exome sequencing, Riboseq, HLA-peptidomics, somatic cell knockouts and expression and proteomic analyses. Candidates who wish to join the group may contact me at: Yardena.samuels@weizmann.ac.il
Rotation
Available Rotations: 1st, 2nd, 3rd
Immunotherapy has sparked new hope for oncology in recent years, due to its remarkable ability to induce durable response in patients with metastatic cancer. It is therefore essential to accurately delineate the interactions of cancer cells with the immune system. The project will use multiomic tools including whole exome sequencing , RNAseq, ribosome profiling, proteomic, HLA-peptidomics and systems biology to decipher the genetic, neo-antigenic and immune landscape in melanoma. Followup functional and immunological analysis of relevant genes and neoantigens will be conducted using novel mouse models
Within the past decade, major advances have been made in the treatment of melanoma through the use of targeted therapy and immunotherapy, however responses are not universal and are not always durable. The project aims to further delineate the interactions of melanoma cells with the immune system to better understand molecular and immune mechanisms of therapeutic response and resistance. Our lab combines genomic tools, systems biology tools, advanced somatic cell knockout and knock-in techniques and various comprehensive mouse model approaches to study melanoma immune-genetics. Our studies link basic biology, computational biology and clinical studies. Trainees will learn sophisticated technologies such as whole exome sequencing, Riboseq, HLA-peptidomics, somatic cell knockouts and expression and proteomic analyses. Candidates who wish to join the group may contact me at: Yardena.samuels@weizmann.ac.il